Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

0(0%)

Results Posted

20%(1 trials)

Terminated

2(25%)

Phase Distribution

Ph phase_3

25%

Ph phase_4

25%

Ph phase_2

25%

Ph not_applicable

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

2(28.6%)

Phase 3Large-scale testing

2(28.6%)

Phase 4Post-market surveillance

2(28.6%)

N/ANon-phased studies

1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Other(1)

Detailed Status

Completed5

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (28.6%)

Phase 32 (28.6%)

Phase 42 (28.6%)

N/A1 (14.3%)

Trials by Status

completed563%

unknown113%

terminated225%

Recent Activity

0 active trials

Showing 5 of 8

terminated

Clinical Trials (8)

Showing 8 of 8 trials

NCT02893371

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated

NCT05115136Phase 3

Using Doxepin for Urticaria

Unknown

NCT04588532Not Applicable

Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch

Completed

NCT03758079Phase 4

Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus

Completed

NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated

NCT00465972Phase 4

The Treatment of Insomnia in Patients With HIV Disease

Completed

NCT00755495Phase 2

Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia

Completed

NCT01268709Phase 2

Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8